• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    International companies to host live webcasts at Deutsche Bank's Depositary Receipts Virtual Investor Conference on November 16th and 17th, 2021

    11/11/21 8:35:00 AM ET
    $AIH
    $AZN
    $BLCT
    $BTCM
    Medical Specialities
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AIH alert in real time by email

    NEW YORK, Nov. 11, 2021 /PRNewswire/ -- Deutsche Bank today announced the lineup for its Depositary Receipts Virtual Investor Conference ("dbVIC") on Tuesday, November 16 and Wednesday, November 17, featuring live webcast presentations from international companies with American Depositary Receipt (ADR) programs in the US. 

    Representatives from participating companies based in Australia, China, Hong Kong, Germany, France and the UK will respond to questions during formal presentations, and will also interact with investors via virtual trade booths. The conference is targeted to all categories of investors and analysts interested in non-US companies.

    There is no fee for participants to log in, attend live presentations and/or ask questions. 

    Please register via this link: www.adr.db.com/dbvic

    Pre-registration is suggested.

    November 16 Agenda (US Eastern Standard Time):

    • 8:00 AM: Hywin ((HYW)
    • 8:30 AM: First Pacific ((Hong Kong: 142_HK, OTC:FPAFY)
    • 9:00 AM: Telstra ((Australia: TLS, OTC:TLSYY)
    • 9:30 AM: Kuke Music Holdings ((KUKE)
    • 10:00 AM: BlueCity Holdings ((BLCT)
    • 10:30 AM: Yiren Digital ((YRD)
    • 11:30 AM: Ecofibre ((Australia: EOF, OTC:EOFBY)
    • 12:00 PM: Ipsen ((Paris: IPN, OTC:IPSEY)
    • 12:30 PM: Travis Perkins ((London: TPK, OTC:TPRKY)

    November 17 Agenda (US Eastern Standard Time):

    • 8:00 AM: HUTCHMED ((HCM, London: HCM))
    • 8:30 AM: China Online Education ((COE)
    • 9:00 AM: NIO ((NIO)
    • 9:30 AM: Aesthetic Medical International Holdings ((AIH)
    • 10:30 AM: Quhuo ((QH)
    • 11:00 AM: AstraZeneca ((London: AZN, NASDAQ:AZN)
    • 11:30 AM: BIT Mining ((BTCM)
    • 12:00PM: Hugo Boss ((Germany: BOSS, OTC:BOSSY)

    The presentations will be available for replay after the Conference. 

    In addition to specializing in administering cross-border equity structures such as American and Global Depositary Receipts, Deutsche Bank provides corporates, financial institutions, hedge funds and supranational agencies around the world with trustee, agency, escrow and related services. The Bank offers a broad range of services for diverse products, from complex securitizations and project finance to syndicated loans, debt exchanges and restructurings.

    Deutsche Bank provides commercial and investment banking, retail banking, transaction banking and asset and wealth management products and services to corporations, governments, institutional investors, small and medium-sized businesses, and private individuals. Deutsche Bank is Germany's leading bank, with a strong position in Europe and a significant presence in the Americas and Asia Pacific.

    Deutsche Bank is sponsoring the Deutsche Bank Depositary Receipt Investor Conference solely for informational purposes. Deutsche Bank does not prepare, review, approve or edit any presentations, statements, documents or other information or materials, whether in written, electronic or verbal form, provided by any company participating in such conference, and disclaims any responsibility for the accuracy or adequacy of any such information or materials. Deutsche Bank is not promoting, endorsing or recommending any company participating in the conference.

    The Depositary Receipts have been registered pursuant to the US Securities Act of 1933 (the "Act"). The investment or investment service which is the subject of this notice is not available to retail clients as defined by the UK Financial Conduct Authority. This notice has been approved and/or communicated by Deutsche Bank AG New York. The services described in this notice are provided by Deutsche Bank Trust Company Americas (Deutsche Bank) or by its subsidiaries and/or affiliates in accordance with appropriate local registration and regulation. Deutsche Bank is providing the attached notice strictly for information purposes and makes no claims or statement, nor does it warrant or in any way represent, as to the accuracy or completeness of the details contained herein or therein. This announcement appears as a matter of record only. Neither this announcement nor the information contained herein constitutes an offer or solicitation by Deutsche Bank or any other issuer or entity for the purchase or sale of any securities nor does it constitute a solicitation to any person in any jurisdiction where solicitation would be unlawful. No part of this notice may be copied or reproduced in any way without the prior written consent of Deutsche Bank. Past results are not an indication of future performance. Copyright© November 2021 Deutsche Bank AG. All rights reserved.

     

    Cision View original content:https://www.prnewswire.com/news-releases/international-companies-to-host-live-webcasts-at-deutsche-banks-depositary-receipts-virtual-investor-conference-on-november-16th-and-17th-2021-301422066.html

    SOURCE dbVIC - Deutsche Bank Depositary Receipts Virtual Investor Conference

    Get the next $AIH alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AIH
    $AZN
    $BLCT
    $BTCM

    CompanyDatePrice TargetRatingAnalyst
    AstraZeneca PLC
    $AZN
    10/16/2025Hold → Sell
    Deutsche Bank
    NIO Inc.
    $NIO
    9/23/2025$8.10 → $8.60Buy
    Citigroup
    HUTCHMED (China) Limited
    $HCM
    9/22/2025$13.75Equal-Weight → Underweight
    Morgan Stanley
    NIO Inc.
    $NIO
    9/16/2025$8.50Neutral → Buy
    UBS
    NIO Inc.
    $NIO
    8/26/2025$8.00Neutral → Overweight
    Analyst
    NIO Inc.
    $NIO
    8/1/2025$5.50Neutral → Outperform
    Macquarie
    NIO Inc.
    $NIO
    6/17/2025$3.70 → $3.80Sell → Neutral
    Goldman
    HUTCHMED (China) Limited
    $HCM
    5/13/2025Buy → Hold
    HSBC Securities
    More analyst ratings

    $AIH
    $AZN
    $BLCT
    $BTCM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    AstraZeneca downgraded by Deutsche Bank

    Deutsche Bank downgraded AstraZeneca from Hold to Sell

    10/16/25 8:19:10 AM ET
    $AZN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Citigroup reiterated coverage on NIO with a new price target

    Citigroup reiterated coverage of NIO with a rating of Buy and set a new price target of $8.60 from $8.10 previously

    9/23/25 10:10:35 AM ET
    $NIO
    Auto Manufacturing
    Industrials

    HUTCHMED downgraded by Morgan Stanley with a new price target

    Morgan Stanley downgraded HUTCHMED from Equal-Weight to Underweight and set a new price target of $13.75

    9/22/25 8:24:03 AM ET
    $HCM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AIH
    $AZN
    $BLCT
    $BTCM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    HUTCHMED Highlights HMPL-A251 Data Presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

    — First investigational drug candidate using the HUTCHMED ATTC technology platform to create potent targeted therapy payloads while mitigating related toxicities — — Unique, highly potent PI3K/PIKK inhibitor payload optimized to exploit antibody-conjugate advantages, with directed delivery and low plasma exposure of free payload — — Preclinical data shows robust antitumor activity with synergistic and bystander killing effects — HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Oct. 23, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited ("HUTCHMED") (Nasdaq/AIM:​HCM; HKEX:​13) today announces preclinical data for HMPL-A251 at the AACR-NCI-EORTC International Conference on Molecular Targets

    10/22/25 8:00:00 PM ET
    $HCM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SOLAI Limited Joins RWA Alliance as a Founding Member to Advance Tokenization of Green Energy Assets

    AKRON, Ohio, Oct. 21, 2025 /PRNewswire/ -- SOLAI Limited (NYSE: SLAI) ("SOLAI" or the "Company"), a leading technology-driven cryptocurrency infrastructure company (previously known as "BIT Mining"), today announced that it has officially joined the Real-World Assets (RWA) Alliance as one of its founding members. The RWA Alliance is dedicated to solving critical industry pain points – such as asset liquidity and opaque valuation – by promoting the tokenization of real-world assets. By leveraging blockchain technology to standardize, divide, and bring transparency to physical assets, the Alliance aims to open up new pathways for the digital transformation of the green energy sector through r

    10/21/25 6:00:00 AM ET
    $BTCM
    EDP Services
    Technology

    BIT Mining Limited to Begin Trading Under New Name "SOLAI Limited" and New Ticker Symbol "SLAI" Effective October 20, 2025

    AKRON, Ohio, Oct. 20, 2025 /PRNewswire/ -- BIT Mining Limited (NYSE:BTCM) ("BIT Mining" or the "Company"), a leading technology-driven cryptocurrency infrastructure company, today announced that effective at the opening of trading on Monday, October 20, 2025, the Company's American Depositary Shares ("ADSs") will begin trading on the New York Stock Exchange under the new name, "SOLAI Limited," and new ticker symbol, "SLAI." In connection with the name change and ticker symbol change, no action is required from current shareholders and the Company's CUSIP number will remain the same. This rebrand reflects the Company's recent strategic pivot into artificial intelligence and blockchain techno

    10/20/25 6:00:00 AM ET
    $BTCM
    EDP Services
    Technology

    $AIH
    $AZN
    $BLCT
    $BTCM
    SEC Filings

    View All

    SEC Form 6-K filed by HUTCHMED (China) Limited

    6-K - HUTCHMED (China) Ltd (0001648257) (Filer)

    10/23/25 6:11:48 AM ET
    $HCM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by AstraZeneca PLC

    6-K - ASTRAZENECA PLC (0000901832) (Filer)

    10/22/25 8:07:20 AM ET
    $AZN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by HUTCHMED (China) Limited

    6-K - HUTCHMED (China) Ltd (0001648257) (Filer)

    10/21/25 6:09:40 AM ET
    $HCM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AIH
    $AZN
    $BLCT
    $BTCM
    Leadership Updates

    Live Leadership Updates

    View All

    SOLAI Limited Joins RWA Alliance as a Founding Member to Advance Tokenization of Green Energy Assets

    AKRON, Ohio, Oct. 21, 2025 /PRNewswire/ -- SOLAI Limited (NYSE: SLAI) ("SOLAI" or the "Company"), a leading technology-driven cryptocurrency infrastructure company (previously known as "BIT Mining"), today announced that it has officially joined the Real-World Assets (RWA) Alliance as one of its founding members. The RWA Alliance is dedicated to solving critical industry pain points – such as asset liquidity and opaque valuation – by promoting the tokenization of real-world assets. By leveraging blockchain technology to standardize, divide, and bring transparency to physical assets, the Alliance aims to open up new pathways for the digital transformation of the green energy sector through r

    10/21/25 6:00:00 AM ET
    $BTCM
    EDP Services
    Technology

    HUTCHMED Announces Appointment of Independent Non-executive Director and Member of Board Committee

    HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Oct. 14, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited ("HUTCHMED" or the "Company") (Nasdaq/AIM:​HCM, HKEX:​13) today announces that Professor Tan Shao Weng, Daniel (Chen Shaowen) is appointed as an Independent Non-executive Director and a member of the Technical Committee of the Company with effect from October 15, 2025. Professor Tan, aged 47, has over 20 years of experience in oncology, with his main research interests focusing on thoracic, head and neck malignancies, and drug development. He is the head of the Division of Clinical Trials and Epidemiological Sciences and a senior consultant in the Division of Medical Oncology at the N

    10/14/25 4:30:00 AM ET
    $HCM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    HUTCHMED Announces Appointment of Acting Chief Executive Officer

    HONG KONG and SHANGHAI and FLORHAM PARK, N.J, Aug. 25, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited ("HUTCHMED") (Nasdaq/AIM:​HCM; HKEX:​13) today announces that Dr Weiguo Su, an Executive Director of the Company, will take a leave of absence from his duties as Chief Executive Officer due to health reasons. In light of this, the Board of Directors has appointed Mr Johnny Cheng, an Executive Director and Chief Financial Officer of the Company, as Acting Chief Executive Officer with immediate effect, in addition to his role as Chief Financial Officer. Dr Dan Eldar, Chairman and Non-executive Director, said, "The Board expresses its full support for Dr Su and wishes him a speedy recover

    8/24/25 8:20:00 PM ET
    $HCM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AIH
    $AZN
    $BLCT
    $BTCM
    Financials

    Live finance-specific insights

    View All

    Baxdrostat met the primary endpoint in Bax24 Phase III trial in patients with resistant hypertension

    Baxdrostat demonstrated a statistically significant and highly clinically meaningful reduction in 24-hour ambulatory systolic blood pressure compared with placebo Positive high-level results from the Bax24 Phase III trial showed baxdrostat demonstrated a statistically significant and highly clinically meaningful reduction in ambulatory 24-hour average systolic blood pressure (SBP) compared with placebo at 12 weeks. Efficacy was observed throughout the 24-hour period, including early morning, when patients with hypertension are at a higher risk of cardiovascular events.1-3 Patients with treatment-resistant hypertension (rHTN) received baxdrostat 2mg or placebo on top of standard of care.

    10/7/25 7:00:00 AM ET
    $AZN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    51Talk Online Education Group Announces Second Quarter 2025 Results

    SINGAPORE, Sept. 3, 2025 /PRNewswire/ -- 51Talk Online Education Group ("51Talk" or the "Company") (NYSE American: COE), a global online education platform with core expertise in English education, announced its unaudited results for the second quarter ended June 30, 2025. Second Quarter 2025 Financial and Operating Highlights Gross billings[1] for the second quarter of 2025 were US$28.5 million, a 79.7% growth from US$15.9 for the second quarter of 2024.Net revenues for the second quarter of 2025 were US$20.4 million, an 86.1% increase from US$11.0 million for the second quarter of 2024.The number of quarterly active students with attended lesson consumption for the second quarter of 2025

    9/3/25 5:00:00 AM ET
    $COE
    Other Consumer Services
    Real Estate

    NIO Inc. Reports Unaudited Second Quarter 2025 Financial Results

    Quarterly Total Revenues Reached RMB19,008.7 million (US$2,653.5 million)iQuarterly Vehicle Deliveries were 72,056 units SHANGHAI, China, Sept. 02, 2025 (GLOBE NEWSWIRE) -- NIO Inc. (NYSE:NIO, HKEX: 9866, SGX: NIO)) ("NIO" or the "Company"), a pioneer and a leading company in the global smart electric vehicle market, today announced its unaudited financial results for the second quarter ended June 30, 2025. Operating Highlights for the Second Quarter of 2025 Vehicle deliveries were 72,056 in the second quarter of 2025, representing an increase of 25.6% from the second quarter of 2024, and an increase of 71.2% from the first quarter of 2025. The deliveries consisted of 47,132 vehicles fr

    9/2/25 5:30:42 AM ET
    $NIO
    Auto Manufacturing
    Industrials

    $AIH
    $AZN
    $BLCT
    $BTCM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by 51Talk Online Education Group

    SC 13D/A - 51Talk Online Education Group (0001659494) (Subject)

    12/17/24 4:07:04 PM ET
    $COE
    Other Consumer Services
    Real Estate

    SEC Form SC 13D filed by Quhuo Limited

    SC 13D - QUHUO Ltd (0001781193) (Subject)

    10/15/24 7:19:18 PM ET
    $QH
    Real Estate

    SEC Form SC 13D filed by Quhuo Limited

    SC 13D - QUHUO Ltd (0001781193) (Subject)

    10/15/24 7:17:52 PM ET
    $QH
    Real Estate